Table 1.
Baseline characteristics of the 320 patients with ICH.
| Total (n=320) | SAP development | ICU admission | |||||
|---|---|---|---|---|---|---|---|
| SAP (n=126) | Non-SAP(n=194) | P value | ICU (n=112) | Non-ICU (n=208) | P value | ||
| Demographics | |||||||
| Age, years, median (IQR) | 62.5 (51.3-73.0) | 65.5 (52-78) | 62 (50-71.25) | 0.103 | 63.5 (51.0-74.0) | 62.0 (52.0-72.0) | 0.781 |
| Sex, male, n (%) | 213 (66.6%) | 87 (69%) | 126 (64.9%) | 0.448 | 79 (70.5%) | 134 (64.4%) | 0.269 |
| Clinical features | |||||||
| GCS, median (IQR) | 13 (7-15) | 9 (6-12) | 15 (11-15) | <0.001 | 9 (6-12) | 15 (10-15) | <0.001 |
| NIHSS, median (IQR) |
11 (3-35) | 19 (11-35) | 5 (2-14) | <0.001 | 20 (12.3-35) | 5 (2-14.8) | <0.001 |
| Hematoma volume, ml, mean±SD |
25.7 ± 20.8 | 32.4 ± 28.5 | 20.0 ± 17.6 | <0.001 | 36.4 ± 29.4 | 19.9 ± 26.8 | <0.001 |
| NLR, median (IQR) | 6.78 (3.68-12.27) |
10.30 (6.46-15.60) |
4.79 (2.82-8.95) |
<0.001 | 10.2 (6.5-15.4) | 4.97 (2.88-9.72) | <0.001 |
| SII, median (IQR) | 1349.50 (755.28-2665.64) |
2271.18 (1140.25-3232.95) |
1018.04 (608.02-2075.39) |
<0.001 | 2271.18(1167.97-3275.65) | 1033.87 (609.60-2254.91) | <0.001 |
| PLR, median (IQR) | 169.98 (122.03-246.61) |
193.85 (133.87-288.69) |
159.38 (115.96-211.16) |
0.001 | 188.00 (131.45-289.16) |
163.49 (119.42-217.14) | 0.008 |
| SIRI, median (IQR) | 3.93 (1.82-7.45) | 5.82 (2.96-11.67) | 2.82 (1.36-5.56) | <0.001 | 6.68(2.92-11.13) | 3.02 (1.53-6.00) | <0.001 |
| Medical history | |||||||
| Smoking, n (%) | 71 (22.2%) | 29 (23.0%) | 42 (21.6%) | 0.774 | 28 (25.0%) | 43 (20.7%) | 0.374 |
| Drinking, n (%) | 40 (12.5%) | 14 (11.1%) | 26 (13.4%) | 0.545 | 13 (11.6%) | 27 (13%) | 0.723 |
| Hypertension, n (%) | 228 (71.3%) | 87 (69%) | 141 (72.7%) | 0.483 | 76 (67.9%) | 152 (73.1%) | 0.325 |
| Diabetes, n (%) | 43 (13.4%) | 15 (11.9%) | 28 (14.4%) | 0.517 | 16 (14.3%) | 27 (13.0%) | 0.744 |
| Hyperlipidemia, n (%) | 24 (7.5%) | 6 (4.8) | 18 (9.3%) | 0.134 | 5 (4.5%) | 19 (9.1%) | 0.130 |
| COPD, n (%) | 11 (3.4%) | 6 (4.8%) | 5 (2.6%) | 0.352 | 4 (3.6%) | 7(3.4%) | 0.923 |
| Treatment | |||||||
| Nasogastric tube, n (%) | 183 (57.1%) | 106(84.1%) | 77(39.7%) | <0.001 | 97 (86.6%) | 86 (41.3%) | <0.001 |
| Neurosurgery, n (%) | 96 (30.0%) | 62(49.2%) | 34(17.5%) | <0.001 | 60 (53.6%) | 36 (11.3%) | <0.001 |
ICH, intracerebral hemorrhage; IQR, interquartile range; RR, relative risk; CI, confidence interval; GCS, Glasgow Coma Scale; NIHSS, National Institute of Health Stroke Scale; NLR, neutrophil-to-lymphocyte ratio; SII, systemic immune-inflammation index; PLR, platelet-to-lymphocyte ratio; SIRI, systemic inflammation response index; COPD, chronic obstructive pulmonary disease. The P values < 0.05 are written in bold text.